News May 03, 2024 Basel research paves way for new drugs Chemists at the University of Basel have developed a new synthesis approach to artificially create terpenes. These contain substances that can be...
News Mar 13, 2024 PSI developing new cancer therapy Researchers from the Paul Scherrer Institute (PSI) have developed a radiopharmaceutical to combat metastatic neuroendocrine tumors. After having ...
News Feb 20, 2024 ETH heads up new chip initiative The Swiss Federal Institute of Technology in Zurich (ETH) is heading up an initiative for the domestic production of chips. The program aims to s...
News Feb 19, 2024 Solita opens new office in Zurich under its Intellishore brand Solita, the Finnish data analysis and strategic consulting firm, is opening an office in Zurich under its Danish brand Intellishore. Intellishore...
News Jan 18, 2024 PSI explores new avenues in qubit research Researchers at the Paul Scherrer Institute (PSI) in the canton of Aargau have taken another step towards developing qubits with long lifetimes. T...
News May 22, 2024 CUTISS secures 25 million Swiss francs from investors CUTISS has closed a first Series C financing round in the amount of 25 million Swiss francs. With this, the life sciences company with a focus on...
News May 21, 2024 InSphero partners with Genome Biologics The biotech company InSphero has signed an agreement with Genome Biologics to commercialize the 3D Cardiac Organoid Platform. The platform is at ...
News Dec 06, 2023 EPFL’s new AI Center to pioneer AI research and collaboration in Switzerland The Ecole Polytechnique Fédérale de Lausanne (EPFL) has launched its new AI Center. This new hub is dedicated to exploring how safe and effective...
News Nov 29, 2023 Meditron, EPFL’s new Large Language Model for medical knowledge EPFL researchers have unveiled Meditron, a groundbreaking open-source Large Language Model (LLM) specifically tailored for the medical field.
News May 15, 2024 Allegria Therapeutics raises 3.5 million dollars in seed financing round Allegria Therapeutics has received seed funding of 3.5 million dollars from the founding investor Forty51 Ventures. The biotech startup is develo...
News Nov 17, 2023 Geistlich Pharma launches new education program Geistlich Pharma is launching the Geistlich myGuide education program with a focus on dentistry and regenerative dentistry. The scientific partne...
News Nov 03, 2023 A new gel offers targeted relief for ulcerative colitis patients Researchers at the University of Bern have developed a lipid gel for direct, localized treatment of ulcerative colitis, aiming to reduce side eff...
News May 10, 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
News Oct 03, 2023 Microsoft Switzerland establishes a new office in Geneva Microsoft Switzerland boosts innovation and connectivity in French-speaking Switzerland with its strategic move to a modern hub in Geneva’s Westh...
News Oct 04, 2023 biGENIUS receives 2 million euros for new cloud product biGENIUS has secured financing of 2 million euros. This funding was granted following the release of biGENIUS-X. The new cloud solution for analy...
News May 07, 2024 UZH researching innovative cancer therapy Researchers from the University of Zurich (UZH) are in the process of developing new cancer therapeutics. Known as radiotheranostics, these drugs...
News Sep 21, 2023 Kandou secures USD 72 million launch its new game-changing product Vaud-based Kandou has raised USD 72 million propelling its global expansion and the introduction of its game-changing product, Regli, to the mark...